Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP261897.RAhr_2uOuln_rWrbs_oLts1BvdRxYX6GAe0PYYGcijiIE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP261897.RAhr_2uOuln_rWrbs_oLts1BvdRxYX6GAe0PYYGcijiIE130_assertion type Assertion NP261897.RAhr_2uOuln_rWrbs_oLts1BvdRxYX6GAe0PYYGcijiIE130_head.
- NP261897.RAhr_2uOuln_rWrbs_oLts1BvdRxYX6GAe0PYYGcijiIE130_assertion description "[Materials and methods Immunoreactivity for bcl-2 was examined in 10 samples of benign prostatic hyperplasia (BPH), 13 of primary prostatic adenocarcinoma, 15 of high-grade PIN and 18 of low-grade PIN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261897.RAhr_2uOuln_rWrbs_oLts1BvdRxYX6GAe0PYYGcijiIE130_provenance.
- NP261897.RAhr_2uOuln_rWrbs_oLts1BvdRxYX6GAe0PYYGcijiIE130_assertion evidence source_evidence_literature NP261897.RAhr_2uOuln_rWrbs_oLts1BvdRxYX6GAe0PYYGcijiIE130_provenance.
- NP261897.RAhr_2uOuln_rWrbs_oLts1BvdRxYX6GAe0PYYGcijiIE130_assertion SIO_000772 10619965 NP261897.RAhr_2uOuln_rWrbs_oLts1BvdRxYX6GAe0PYYGcijiIE130_provenance.
- NP261897.RAhr_2uOuln_rWrbs_oLts1BvdRxYX6GAe0PYYGcijiIE130_assertion wasDerivedFrom befree-20150227 NP261897.RAhr_2uOuln_rWrbs_oLts1BvdRxYX6GAe0PYYGcijiIE130_provenance.
- NP261897.RAhr_2uOuln_rWrbs_oLts1BvdRxYX6GAe0PYYGcijiIE130_assertion wasGeneratedBy ECO_0000203 NP261897.RAhr_2uOuln_rWrbs_oLts1BvdRxYX6GAe0PYYGcijiIE130_provenance.